RESEARCH &
COLLABORATION
Better Data for Better Research DISCOVERIES.
Enrich your data and expand your research opportunities as part of a global community advancing safer and more effective therapies for better patient care.
TriNetX puts longitudinal, globally sourced patient data into your hands — and in front of trial sponsors seeking your experience. Healthcare organizations across the globe use the TriNetX LIVE™ platform every day to empower their researchers, collaborate with other institutions, and participate in more clinical trials. The result? Opportunity for you and your patients.
TriNetX provides a world of opportunities to Penn State investigators.
Neal Thomas
Associate Dean for Clinical Research, Penn State College of Medicine
Enrich your data.
-
Harmonize all your data, from EHR and other sources, on our powerful platform for rapid cohort discovery and analysis.
-
Participate in our global, collaborative healthcare networks to conduct deeper real-world research. We map local codes to common terminologies, including ICD-10-CM and LOINC.
-
Where possible, link your EHR data with claims, mortality records, and other sources from the TriNetX network for a more complete picture of the patient. Query this enriched dataset on our platform or download a dataset.
Expand your research opportunities.
-
Increase engagement with trial sponsors seeking partners for interventional and chart review studies.
-
Collaborate with peer institutions on multi-site, investigator-initiated research.
-
Use derived data for academic publications and grant submissions.
Healthcare organizations around the world choose TriNetX
The results are in. Healthcare organizations within our community have advanced their own research, secured more sponsored trials, and improved patient outcomes. Let our healthcare partners tell you how.
Join the TriNetX Revolution
Explore possibilities of real-world data to accelerate clinical research and advance patient care.
Life Science Partners
When you join TriNetX, you attract opportunity from study sponsors advancing new treatments around the world. Become part of the data ecosystem that life sciences and healthcare organizations are relying on more every day to improve patients’ lives.
Watch On Demand
Solutions to Amplify Your Clinical Real-World Data Research
Join us as we examine how rich and timely clinical data, unified in a research-ready environment, can provide clinical researchers with the best opportunity to accelerate published research and advance outcomes.
Gain new insights.
We’ve joined the TriNetX network to improve the way we use data to drive research across NHSGGC and with our partner organizations. Joining the network will also help us share information about our patient populations in a secure and de-identified way and to participate in cutting-edge clinical trials and research that benefits us all.
Attract more trials.
We are getting an average of one to two study opportunities per week … the pipeline of studies TriNetX has exposed us to is amazing. It’s been a 20- to 30-fold increase of opportunities compared to what we were getting from many other sources.
Deliver better care.
[Our research] can have a huge difference in whether someone continues treatment or is relegated to palliative care… It’s a crucial discovery in making potentially life or death treatment decisions.
What Drives Us
Hear from Gadi Lachman, the President and Chief Executive Officer of TriNetX, as he shares how we are supporting the global research community to empower better care decisions for patients faster.
TriNetX Healthcare Organization News
TriNetX-enabled research drives learning at ASH 2022
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific...
Journal of Clinical Hypertension – “First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes”
This study was written by Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX, and Sarah Hilderbrand, MSc and published in the Journal of Clinical...
World Journal of Diabetes – “Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes”
This study published in the World Journal of Diabetes evaluates the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in...
Join the Healthcare Research Revolution
Ready to learn how your organization can join the growing TriNetX network of healthcare organizations?